Concerns growing over domestic market entry of leading generic companies

Published: 2009-07-22 06:59:00
Updated: 2009-07-22 06:59:00
Korean pharmaceutical firms are jittery over possible entry of leading foreign companies, such as Cipla Limited and Teva.

Cipla Limited is looking to seek Korean partners to market their hundreds of generic medications it produces here in Korea.

Cipla is a prominent Indian pharmaceutical co...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.